Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
2.000
0.00 (0.00%)
Dec 31, 2025, 4:00 PM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $287.18 million as of January 2, 2026. Its market cap has decreased by -5.70% in one year.
Market Cap
287.18M
Enterprise Value
185.17M
Revenue
25.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.00
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 287.18M, a decrease of -46.66%. That is a compound annual growth rate of -11.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 723.19M |
| Elite Pharmaceuticals | 503.55M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 355.02M |
| CytoDyn | 325.20M |
| OpGen | 160.13M |